In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroPharmacokinetics and tissue penetration of enoxacinUptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cellsIn vitro activity of PD 127,391, an enhanced-spectrum quinoloneOfloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersIntraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.Activities of new quinoline derivatives against genital pathogens.The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepaciaA pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.Enoxacin as one day oral treatment of men with anal or pharyngeal gonorrhoea.Alterations of coagulase-negative staphylococcal flora in cardiac surgery patients: comparative study between cefamandole and pefloxacin perioperative prophylaxis.Ofloxacin: in vitro activity against recently isolated gram-negative bacterial strains.
P2860
Q24670241-1CE6301F-4FE3-4539-8D16-AE1D29878511Q24674802-B8A24602-0355-495D-AB0E-7512E461964EQ24676018-B52E8AF6-BE2E-4E54-BE88-23825E5FD7DEQ28361070-B846EFD8-25CF-4DFE-96FB-54B0EA6E74CFQ34687048-C54F0135-DEB9-4854-8CBE-866219D625EDQ35245897-886480C6-5F9D-4303-9AAD-291C81AF9F46Q35285078-247EC71B-6140-44E6-8B57-0F3383FD1445Q35537723-6D2E9354-611C-41F8-B2FC-1CDD665C9C0EQ35568919-48E204ED-D824-4B2A-B482-EEFBB6BD3C28Q35572870-DB1F97E7-344C-440D-AC47-20D15AC679DCQ35807882-5446D078-7E4A-4647-A0B2-7BB07E88F7A9Q35836280-A355DC89-114A-4876-B91A-7EB073ED6153Q39849761-0D9C7F32-4F0D-4291-8B80-EA780CD78F88Q41785599-16CEAC00-BA8E-48E0-8441-D5FD7589236AQ46926939-B6EA247F-64F4-4562-8FEC-0A506CB35653Q54356943-86ACB355-4401-489C-A5E4-F0CBBC3B5D88
P2860
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents
description
1984 nî lūn-bûn
@nan
1984 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մարտին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
In-vitro activity of enoxacin ...... of other antimicrobial agents
@ast
In-vitro activity of enoxacin ...... of other antimicrobial agents
@en
In-vitro activity of enoxacin ...... of other antimicrobial agents
@nl
type
label
In-vitro activity of enoxacin ...... of other antimicrobial agents
@ast
In-vitro activity of enoxacin ...... of other antimicrobial agents
@en
In-vitro activity of enoxacin ...... of other antimicrobial agents
@nl
prefLabel
In-vitro activity of enoxacin ...... of other antimicrobial agents
@ast
In-vitro activity of enoxacin ...... of other antimicrobial agents
@en
In-vitro activity of enoxacin ...... of other antimicrobial agents
@nl
P2093
P356
P1476
In-vitro activity of enoxacin ...... of other antimicrobial agents
@en
P2093
P304
P356
10.1093/JAC/13.3.237
P407
P577
1984-03-01T00:00:00Z